Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

63 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : SYNLAB AG, Q1 2024 Earnings Call, May 08, 2024
SYNLAB delivers strong performance in Q1 2024
EQ
SYNLAB : Presentation on the Q1 Financial Report 2024
PU
DD: SYNLAB AG: Mathieu Floreani, sell
EQ
SYNLAB : Agenda and convening of the general meeting
PU
Transcript : SYNLAB AG, 2023 Earnings Call, Mar 25, 2024
SYNLAB delivers robust performance in FY 2023
EQ
Transcript : SYNLAB AG, Q3 2023 Earnings Call, Nov 08, 2023
Continued strong performance in the third quarter of 2023
EQ
SYNLAB AG publishes Joint Reasoned Statement on public acquisition offer by Cinven
EQ
SYNLAB launches revolutionary bipolar disorder diagnostic test: myEDIT-B
EQ
SYNLAB launches revolutionary bipolar disorder diagnostic test: myEDIT-B
PU
SYNLAB AG: SYNLAB agrees to sell its veterinary diagnostics business to Mars
EQ
Transcript : SYNLAB AG, H1 2023 Earnings Call, Aug 09, 2023
Declining covid tests and costs weigh on lab chain Synlab
DP
Hardly any Covid tests left and rising costs weigh on laboratory services provider Synlab
DP
SYNLAB AG: Continued strong performance in the second quarter of 2023
EQ
SYNLAB AG: SYNLAB invests in innovative Healthcare Centre in Florence
EQ
Laboratory services provider Synlab divests Swiss business
DP
SYNLAB AG: SYNLAB agrees to sell Swiss business to Sonic Healthcare
EQ
Transcript : SYNLAB AG, Q1 2023 Earnings Call, May 10, 2023
Ebbing of the pandemic continues to benefit Synlab - share price rises nonetheless
DP
SYNLAB AG: SYNLAB reports strong start to fiscal year 2023
EQ
Transcript : SYNLAB AG, Q4 2022 Earnings Call, Mar 16, 2023
SYNLAB AG: SYNLAB delivers robust underlying growth in FY 2022
EQ
Synlab extends contracts of group CEO Floreani and CFO Badarani
DP
SYNLAB AG: Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO
EQ
Transcript : SYNLAB AG, 2022 Sales/ Trading Statement Call, Feb 07, 2023
Synlab expects lower sales and operating profit in 2023
DP
SYNLAB AG: SYNLAB reports trading update for FY 2022 and revises FY 2023 guidance from lower COVID-19 testing
EQ
Transcript : SYNLAB AG, Q3 2022 Earnings Call, Nov 10, 2022
SYNLAB AG: SYNLAB reports strong underlying performance in 9M 2022, confirms 2022 guidance and releases 2023 guidance
EQ
Transcript : SYNLAB AG, Q2 2022 Earnings Call, Aug 11, 2022
SYNLAB reports solid H1 2022 results and raises 2022 revenue guidance
EQ
SYNLAB Seeks M&A
CI
Transcript : SYNLAB AG - Analyst/Investor Day
Transcript : SYNLAB AG, Q1 2022 Earnings Call, May 12, 2022
SYNLAB reports a strong start to the fiscal year 2022
EQ
SYNLAB AG: SYNLAB Medical Congress: making healthcare future-proof with advanced diagnostics
EQ
SYNLAB AG : Notification and public disclosure of transactions by persons
EQ
Transcript : SYNLAB AG, Q4 2021 Earnings Call, Mar 16, 2022
SYNLAB AG: SYNLAB achieves record results in 2021 and exceeds all targets set at the IPO
EQ
SYNLAB AG: SYNLAB joins the United Nations Global Compact initiative
EQ
SYNLAB acquires Sistemas Genómicos of the Ascires Group in Spain, further strengthening its European leadership in genetics
EQ
SYNLAB AG : Notification and public disclosure of transactions by persons
EQ
SYNLAB delivers strong 9M 2021 results, on track to significantly exceed 2021 financial targets set at IPO
EQ
SYNLAB : delivers outstanding financial and operational results in Q2 and H1 2021
EQ
SYNLAB : and IATA partner to facilitate safe and easy travelling
EQ
SYNLAB AG: SYNLAB and Medica Sur reach an agreement for SYNLAB to acquire 100 percent of Laboratorio Médico Polanco and Laboratorio Clinicos de Puebla
EQ
SYNLAB: SYNLAB and AXA Partners enter a partnership to enhance safe travel this summer
EQ
No results for this search
  1. Stock Market
  2. Advanced search
  3. Mathieu Floreani
  4. News
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW